M. Núñez

发表

Hepatitis B Virus Genotypes and Lamivudine Resistance Mutations in HIV/Hepatitis B Virus-Coinfected Patients

V. Soriano, J. Sheldon, J. García-Samaniego, 2007, Journal of acquired immune deficiency syndromes.

Liver injury after beginning antiretroviral therapy in HIV/hepatitis C virus co-infected patients is not related to immune reconstitution.

V. Soriano, M. Pérez-Olmeda, J. González-lahoz, 2002, AIDS.

Role of Hepatitis C Virus Genotype in the Development of Severe Transaminase Elevation After the Introduction of Antiretroviral Therapy

V. Soriano, M. Pérez-Olmeda, J. González-lahoz, 2002, Journal of acquired immune deficiency syndromes.

Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

V. Soriano, J. Arribas, M. Pérez-Olmeda, 2003 .

Influence of HCV genotype and co‐infection with human immunodeficiency virus on CD4+ and CD8+ T‐cell responses to hepatitis C virus

J. Benito, V. Soriano, J. González-lahoz, 2007, Journal of medical virology.

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

B. Clotet, E. Negredo, V. Soriano, 2005, AIDS.

Long-Term Follow-Up of HIV-Infected Patients with Chronic Hepatitis C Virus Infection Treated with Interferon-Based Therapies

V. Soriano, J. González-lahoz, J. García-Samaniego, 2004, Antiviral therapy.

Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2005, Journal of acquired immune deficiency syndromes.

Activity of tenofovir on hepatitis B virus replication in HIV-co-infected patients failing or partially responding to lamivudine.

V. Soriano, M. Pérez-Olmeda, J. González-lahoz, 2002, AIDS.

Clinical syndromes and consequences of antiretroviral‐related hepatotoxicity

M. Núñez, M. Nunez, 2010, Hepatology.

Higher Risk of Severe Drug-Induced Liver Injury among Hispanic HIV-Infected Patients after Initiation of Highly Active Antiretroviral Therapy

M. Núñez, Zanetta S Lamar, 2011, Journal of the International Association of Physicians in AIDS Care.

Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis.

M. Mendes-Corrêa, M. Núñez, Lísia Gomes Martins de Moura Tomich, 2015, Annals of hepatology.

Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients.

V. Soriano, M. Núñez, M. Nunez, 2005, The Journal of infectious diseases.

Outcome of HCV Genotype 1 Treatment in HIV-Coinfected Patients with Chronic Kidney Disease

M. Núñez, Ana Paula Oppenheimer, James Johnson, 2013, Journal of the International Association of Providers of AIDS Care.

Clearance of human herpesvirus type 8 viraemia in HIV-1-positive patients with Kaposi's sarcoma treated with liposomal doxorubicin

D. Podzamczer, V. Soriano, J. González-lahoz, 2000, AIDS.

Outcomes in HIV/HBV-Coinfected Patients in the Tenofovir Era Are Greatly Affected by Immune Suppression

A. J. Huang, M. Núñez, M. Nunez, 2015, Journal of the International Association of Providers of AIDS Care.

HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.

M. Núñez, Michelle Jones, M. Jones, 2011, Current opinion in HIV and AIDS.

Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center

V. Soriano, J. González-lahoz, B. Ramos, 2005, HIV clinical trials.

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C

V. Soriano, P. López-Serrano, A. Mariño, 2008, AIDS.

Use of electronic health record clinical decision support tool for HCV birth cohort screening

A. Dharod, M. Núñez, C. Campos, 2017, Journal of viral hepatitis.

Clearance of hepatitis C virus in HIV‐infected patients with multiple chronic viral hepatitis

V. Soriano, J. González-lahoz, M. Núñez, 2007, Journal of viral hepatitis.

Hepatotoxicity of Antiviral Agents

M. Núñez, M. Nunez, 2013 .

Virological Rather Than Host Factors Are Associated With Transaminase Levels Among HIV/HCV-Coinfected Patients

Nathan J. Shores, M. Núñez, I. Maida, 2010, Journal of the International Association of Physicians in AIDS Care.

Longer Duration of HBV-Active Antiretroviral Therapy is Linked to Favorable Virological Outcome in HIV-HBV Co-infected Patients

M. Núñez, Tsan-Hung Lee, 2009, HIV clinical trials.

Baseline Serum Hepatitis C Virus (HCV) RNA Level and Response at Week 4 Are the Best Predictors of Relapse After Treatment With Pegylated Interferon Plus Ribavirin in HIV/HCV-Coinfected Patients

V. Soriano, A. Mariño, C. Miralles, 2007, Journal of acquired immune deficiency syndromes.

Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity

S. Babudieri, Nathan J. Shores, K. High, 2015, Clinics.

Pulmonary cryptococcosis in the immunocompetent host. Therapy with oral fluconazole: a report of four cases and a review of the literature.

R. Chin, M. Núñez, J. Peacock, 2000, Chest.

Liver enzyme elevation in hepatitis C virus (HCV)-HIV-coinfected patients prior to and after initiating HAART: role of HCV genotypes.

G. D'offizi, S. Babudieri, G. Solinas, 2006, AIDS research and human retroviruses.

Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.

V. Soriano, J. Arribas, M. Pérez-Olmeda, 2003, AIDS.

Gene-gene and gene-environment interactions in HIV-associated nephropathy: A focus on the MYH9 nephropathy susceptibility gene.

B. Freedman, M. Núñez, Anita M. Saran, 2010, Advances in chronic kidney disease.

Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy.

V. Soriano, M. Ríos, M. Núñez, 2008, AIDS research and human retroviruses.

Consensus conference on chronic viral hepatitis and HIV infection: updated Spanish recommendations

C. Tural, J. Miro, V. Soriano, 2004, Journal of viral hepatitis.

Incidence of anaemia and impact on sustained virological response in HIV/HCV‐coinfected patients treated with pegylated interferon plus ribavirin

V. Soriano, A. Ocampo, V. Asensi, 2008, Journal of viral hepatitis.

Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.

V. Soriano, M. Núñez, P. Rivas, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Incidence of Liver Injury After Beginning Antiretroviral Therapy with Efavirenz or Nevirapine

V. Soriano, J. González-lahoz, M. Núñez, 2003, HIV clinical trials.

Does an Increase in Nevirapine Plasma Levels Cause Complete Virologic Suppression in Patients Experiencing Early Virologic Failure?

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2002, HIV clinical trials.

Short communication: liver toxicity of lopinavir-containing regimens in HIV-infected patients with or without hepatitis C coinfection.

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2004, AIDS research and human retroviruses.

Short communication: interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients.

V. Soriano, J. González-lahoz, M. Núñez, 2003, AIDS research and human retroviruses.

Risk factors for severe hepatic injury after introduction of highly active antiretroviral therapy.

V. Soriano, J. Mendoza, M. Núñez, 2001 .

Liver toxicity caused by nevirapine.

V. Soriano, I. Jiménez-Nácher, M. Núñez, 2002, AIDS.

Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.

V. Soriano, M. Núñez, M. Nunez, 2005, Journal of hepatology.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

V. Soriano, J. González-lahoz, P. Labarga, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Suppression of HBV by Tenofovir in HBV/HIV Coinfected Patients: A Systematic Review and Meta-Analysis

D. Pillay, N. Kuzushita, S. Mauss, 2013, PloS one.

Lack of 'occult' hepatitis B virus infection in HIV-infected patients.

V. Soriano, M. Pérez-Olmeda, M. Núñez, 2002, AIDS.

Evolution of T-cell Responses to Hepatitis C Virus (HCV) during Pegylated Interferon plus Ribavirin treatment in HCV-Monoinfected and in HCV/HIV-Coinfected Patients

J. Benito, V. Soriano, C. de Mendoza, 2007, Antiviral therapy.

Levels of serum markers of liver inflammation and fibrosis in patients with chronic hepatitis C virus infection according to HIV status and antiretroviral use.

Abbie Connoy, M. Núñez, Jolyn Turner, 2011, AIDS research and human retroviruses.

Natural Pregnancies in HIV-Serodiscordant Couples Receiving Successful Antiretroviral Therapy

V. Soriano, M. Leal, J. del Romero, 2006, Journal of acquired immune deficiency syndromes.

Management of HIV and hepatitis virus coinfection

M. Mendes-Corrêa, M. Núñez, M. Nunez, 2010, Expert opinion on pharmacotherapy.

Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.

V. Soriano, Nathan J. Shores, M. Núñez, 2008, Journal of hepatology.

Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study.

J. J. de la Cruz, V. Soriano, M. Vogel, 2004, Clinical Infectious Diseases.

Double invasive fungal infection due to dematiaceous moulds in a renal transplant patient

E. Palavecino, M. Núñez, Guy El Helou, 2018, BMJ Case Reports.

Diabetic Foot Infection and Select Comorbidities Drive Readmissions in Outpatient Parenteral Antimicrobial Therapy.

M. Núñez, Andrew Barnes, 2020, The American journal of the medical sciences.

Hepatitis B and C

M. Mendes-Corrêa, M. Núñez, J. Carlin, 2017 .

Hepatotoxicity of antiretrovirals: incidence, mechanisms and management.

Marina Núñez, M. Núñez, M. Nunez, 2006, Journal of hepatology.

Management of chronic hepatitis B and C in HIV-coinfected patients.

V. Soriano, M. Núñez, P. Barreiro, 2006, The Journal of antimicrobial chemotherapy.

Selection of Hepatitis B Virus Polymerase Mutations in HIV-Coinfected Patients Treated with Tenofovir

F. Tacke, B. Rodés, V. Soriano, 2005, Antiviral therapy.

Complications in treating chronic hepatitis B in patients with HIV

V. Soriano, J. González-lahoz, J. Sheldon, 2005, Expert opinion on pharmacotherapy.

Management of patients co-infected with hepatitis B virus and HIV.

V. Soriano, M. Núñez, M. Nunez, 2005, The Lancet. Infectious diseases.

Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.

V. Soriano, M. Puoti, M. Núñez, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons.

V. Soriano, J. Sheldon, B. Ramos, 2006, AIDS.

Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy.

V. Soriano, J. González-lahoz, B. Ramos, 2006, AIDS research and human retroviruses.

New Hopes for HIV and HCV Coinfection in 2004

V. Soriano, M. Núñez, M. Nunez, 2004, HIV clinical trials.

Risk Factors for Severe Hepatic Injury After Introduction of Highly Active Antiretroviral Therapy

V. Soriano, M. Núñez, L. Martín-Carbonero, 2001, Journal of acquired immune deficiency syndromes.

Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: therapeutic implications.

V. Soriano, M. Pérez-Olmeda, J. González-lahoz, 2003, AIDS research and human retroviruses.

Highlights from the 1st International Workshop on HIV and Hepatitis Co-infection

M. Núñez, M. Nunez, 2005, HIV clinical trials.

Viral Hepatitis and HIV: Update and Management

M. Mendes-Corrêa, M. Núñez, 2013, Antiviral Therapy.

Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.

V. Soriano, V. Sánchez-Margalet, S. Babudieri, 2008, AIDS research and human retroviruses.

Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis B Extensively Exposed to Antiretroviral Therapy with Anti-HBV Activity

V. Soriano, G. Sotgiu, J. González-lahoz, 2006, HIV clinical trials.

Impact of Ribavirin Exposure on Early Virological Response to Hepatitis C Therapy in HIV-Infected Patients with Chronic Hepatitis C

V. Soriano, P. Arazo, A. Ocampo, 2005, Antiviral therapy.

Severe Liver Disease Associated With Prolonged Exposure to Antiretroviral Drugs

C. Toro, V. Soriano, G. Sotgiu, 2006, Journal of acquired immune deficiency syndromes.

Tolerance of didanosine as enteric-coated capsules versus buffered tablets.

V. Soriano, J. González-lahoz, M. Núñez, 2004, AIDS Patients Care and STDs.

Hepatotoxicity of Antiretrovirals

V. Soriano, M. Núñez, M. Nunez, 2005, Drug safety.

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial.

V. Soriano, P. Arazo, A. Ocampo, 2007, AIDS research and human retroviruses.

Low Yield of Hepatitis B Virus DNA Testing in the Absence of Surface Antigen.

E. Palavecino, M. Núñez, Krupa Daniel, 2020, American journal of medical quality : the official journal of the American College of Medical Quality.

Routine hepatitis B virus DNA testing in human immunodeficiency virus–infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence

M. Núñez, 2010, Hepatology.

Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon a-2 b Plus Ribavirin

V. Soriano, M. Pérez-Olmeda, I. Jiménez-Nácher, 2004 .

SENC (Spanish efavirenz vs. nevirapine comparison) trial: A randomized, open-label study in HIV-infected naive individuals

Marina Núñez, Pablo Barreiro, V. Soriano, 2002, HIV clinical trials.

Clinical benefit of interventions driven by therapeutic drug monitoring

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2005, HIV medicine.

Comparison of the efficacy, safety and predictive value of HIV genotyping using distinct ritonavir-boosted protease inhibitors.

V. Soriano, C. de Mendoza, J. González-lahoz, 2002, International journal of antimicrobial agents.

Different Viral Rebound following Discontinuation of Antiretroviral Therapy in Cases of Infection with Viruses Carrying L74V or Thymidine-Associated Mutations

E. Paxinos, V. Soriano, C. de Mendoza, 2004, Journal of Clinical Microbiology.

Liver Toxicity of Antiretroviral Drugs

M. Núñez, Michelle Jones, M. Jones, 2012, Seminars in Liver Disease.

New paradigms in the management of HIV and hepatitis C virus coinfection

V. Soriano, J. García-Samaniego, M. Núñez, 2005, Current opinion in infectious diseases.

Coinfection with hepatitis C virus increases lymphocyte apoptosis in HIV-infected patients.

J. Benito, V. Soriano, J. González-lahoz, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Response to pegylated interferon plus ribavirin in HIV‐infected patients with chronic hepatitis C due to genotype 4

R. Bruno, V. Soriano, A. De Luca, 2008, Journal of viral hepatitis.

Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B

V. Soriano, S. Babudieri, J. González-lahoz, 2005, HIV clinical trials.

Current concepts in the management and treatment of hepatitis C in HIV-infected patients.

V. Soriano, M. Núñez, M. Nunez, 2005, Annals of hepatology.

Transient hepatitis B surface antigenemia after hepatitis B virus vaccine in an HIV-infected patient.

L. Bachmann, M. Núñez, S. Barbour, 2013, AIDS research and human retroviruses.

Hepatitis C Virus-Rna Clearance in HIV-Coinfected Patients with Chronic Hepatitis C Treated with Pegylated Interferon plus Ribavirin

V. Soriano, J. González-lahoz, J. García-Samaniego, 2003, Antiviral therapy.

Hepatitis C virus and kidney transplantation: Recent trends and paradigm shifts.

M. Núñez, C. Jay, Guy El Helou, 2022, Transplantation reviews.

Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: implications for HCV therapy in HCV/HIV-coinfected patients.

C. Toro, V. Soriano, J. Sheldon, 2007, The Journal of infection.

Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients.

V. Soriano, M. Pérez-Olmeda, J. González-lahoz, 2004, AIDS research and human retroviruses.

Higher efavirenz plasma levels correlate with development of insomnia.

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2001, Journal of acquired immune deficiency syndromes.

Treatment of Chronic Hepatitis C in HIV-Infected Patients with Interferon α-2b Plus Ribavirin

V. Soriano, M. Pérez-Olmeda, I. Jiménez-Nácher, 2003 .

Response to Liposomal Doxorubicin and Clinical Outcome of HIV-1–Infected Patients with Kaposi’s Sarcoma Receiving Highly Active Antiretroviral Therapy

D. Podzamczer, J. González-lahoz, E. Ferrer, 2001, HIV clinical trials.

Response to Interferon-Based Therapies in HIV-Infected Patients with Chronic Hepatitis C Due to Genotype 4

V. Soriano, J. González-lahoz, M. Sánchez-Conde, 2005, Antiviral therapy.

Salvage Treatment with Lopinavir/Ritonavir (Kaletra) in HIV-Infected Patients Failing All Current Antiretroviral Drug Families

V. Soriano, J. González-lahoz, I. Jiménez-Nácher, 2002, HIV clinical trials.

Delayed spontaneous hepatitis C virus elimination in a renal transplant patient following graft rejection

R. Stratta, Francesca Mori Ubaldini, M. Núñez, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

Premature Treatment Discontinuation in HIV/HCV-Coinfected Patients Receiving Pegylated Interferon plus Weight-Based Ribavirin

V. Soriano, F. Blanco, P. Arazo, 2007, Antiviral therapy.

Impact of hepatitis C virus (HCV) on morbidity and mortality rates among HIV-infected patients.

V. Soriano, M. Núñez, L. Martín-Carbonero, 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

JC polyoma virus interacts with APOL1 in African Americans with non-diabetic nephropathy

M. Rocco, C. Langefeld, J. Divers, 2013, Kidney international.

Association of APOL1 variants with mild kidney disease in first-degree relatives of African American patients with non-diabetic end stage renal disease

M. Rocco, C. Langefeld, J. Divers, 2012, Kidney international.

Intensification of antiretroviral therapy.

V. Soriano, M. Núñez, R. Rodríguez-rosado, 2001, AIDS research and human retroviruses.

Salvage therapy for HIV infection: when and how.

V. Soriano, M. Núñez, M. Nunez, 2000, AIDS patient care and STDs.

The albumin‐bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV‐associated hepatocellular carcinoma

D. Pinato, M. Nelson, B. Mínguez, 2018, Alimentary pharmacology & therapeutics.

Rate, causes, and clinical implications of presenting with low CD4+ cell counts in the era of highly active antiretroviral therapy.

V. Soriano, M. Leal, J. González-lahoz, 2003, AIDS research and human retroviruses.

Reduction in liver‐related hospital admissions and deaths in HIV‐infected patients since the year 2002

V. Soriano, J. González-lahoz, M. Sánchez-Somolinos, 2006, Journal of viral hepatitis.

Hydroxyurea plus Didanosine as Maintenance Therapy for HIV-Infected Patients on Long-Term Successful Highly Active Antiretroviral Therapy

V. Soriano, C. de Mendoza, J. González-lahoz, 2003, HIV clinical trials.

Liver transplantation in HIV-HCV coinfected candidates: what is the most appropriate time for evaluation?

V. Soriano, J. González-lahoz, M. Núñez, 2005, AIDS research and human retroviruses.

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV‐coinfected patients

V. Soriano, P. Arazo, A. Ocampo, 2007 .

Failure of hepatitis C therapy in HIV-coinfected drug users is not due to a shift in hepatitis C virus genotype.

V. Soriano, J. González-lahoz, J. García-Samaniego, 2005, The Journal of infectious diseases.

Liver fibrosis stage and HCV genotype distribution in HIV-HCV coinfected patients with persistently normal transaminases.

V. Soriano, P. Labarga, M. Núñez, 2007, AIDS research and human retroviruses.

Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.

V. Soriano, P. Arazo, A. Ocampo, 2006, Journal of viral hepatitis.

Treatment of chronic hepatitis C in HIV-infected patients with interferon alpha-2b plus ribavirin.

V. Soriano, M. Pérez-Olmeda, I. Jiménez-Nácher, 2003, AIDS research and human retroviruses.

Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations.

V. Soriano, C. de Mendoza, I. Jiménez-Nácher, 2003, AIDS.

How effective is HAART in HCV and HIV coinfection?

V. Soriano, M. Núñez, M. Nunez, 2004, AIDS.